Copaxone is owned by Teva....All news received directly from Teva or it's websites is in green
Sunday
EU again turns down Teva's laquinimod
Teva and Active Biotech filed a request for a review of the finding. The result is a setback for the two companies. Laquinimod has been considered a replacement for Teva's high-selling multiple sclerosis treatment Copaxone Click here to read more